Global Nucleic Acid And Gene Therapies In Neuromuscular Disorders market size is expected to reach $11.76 billion by 2030 at 9.4%, rising prevalence of genetic disorders fuels growth in the market
Read More
The Nuclear Protein In Testis Midline Carcinoma Treatment market size is expected to reach $42.21 billion in 2030 at 13.6%, driven by growing adoption of personalized medicine.
Read More
Global Nuclear Medicine market size is expected to reach $17.13 billion by 2030 at 10.7%, cardiovascular disease and cancer surge drive growth in the nuclear medicine market
Read More
Global Nootropics market size is expected to reach $13.23 billion by 2030 at 17.4%, elevated health and wellness spending boosts nootropics market growth
Read More
Global Noonan Syndrome market size is expected to reach $1.23 billion by 2030 at 8.2%, impact of increasing genetic disorder prevalence on the growth of the market
Read More
Global Nontuberculous Mycobacterial Infection market size is expected to reach $21.01 billion by 2030 at 7.3%, segmented as by macrolides, azithromycin, clarithromycin
Read More
The non-surgical cosmetic procedures market is projected to reach $47.37 billion by 2030, growing at 10.5% CAGR, driven by injectables, energy-based devices, and personalized aesthetics.
Read More
Global Non-Small Cell Lung Cancer (NSCLC) market size is expected to reach $70.81 billion by 2030 at 11%, segmented as by squamous cell carcinoma, keratinizing squamous cell carcinoma, non-keratinizing squamous cell carcinoma
Read More
The non-radiographic axial spondyloarthritis therapeutic market is projected to reach $1.72 billion by 2030, growing at 10.6% CAGR, driven by biologics, JAK inhibitors, and early intervention.
Read More
Global Non-Proliferative Diabetic Retinopathy market size is expected to reach $3.96.8 billion by 2030 at 6.8%, segmented as by anti-vascular endothelial growth factor (vegf) therapy, bevacizumab (avastin), ranibizumab (lucentis), aflibercept (eylea)
Read More